Similar Papers

Paper Title
Journal
Date
Author
The association of pre-existing autoimmune disease and immune-related adverse events secondary to immune checkpoint inhibition therapy in a UK multicenter cohort.
...
Journal of Clinical Oncology | VOL. 40
, et. al. ...
01 Jun 2022
Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer.
Amy Cunningham‐Bussel ... Nicole R Leboeuf
Arthritis & rheumatology (Hoboken, N.J.) | VOL. 74
Amy Cunningham‐Bussel, et. al.Amy Cunningham‐Bussel ... Nicole R Leboeuf
25 Jan 2022
Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma.
Marcus Wölffer ... Andrea Forschner
Cancers | VOL. 14
Marcus Wölffer, et. al.Marcus Wölffer ... Andrea Forschner
08 Jan 2022
Use of immune checkpoint inhibitors in patients with solid tumors and pre-existing autoimmune or inflammatory disease: real-world data.
Virginia Calvo ... Mariano Provencio
Lung Cancer Management | VOL. 10
Virginia Calvo, et. al.Virginia Calvo ... Mariano Provencio
02 Jul 2021
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Dysfunctional KLRB1+CD8+ T-cell responses are generated in chronically inflamed systemic sclerosis skin.
Alyxzandria M Gaydosik ... Patrizia Fuschiotti
Annals of the rheumatic diseases | VOL. -
Alyxzandria M Gaydosik, et. al.Alyxzandria M Gaydosik ... Patrizia Fuschiotti
01 Feb 2025
Lipidomics unravels lipid changes in osteoarthritis articular cartilage.
Qiongfei Zhou ... Rik J Lories
Annals of the rheumatic diseases | VOL. -
Qiongfei Zhou, et. al.Qiongfei Zhou ... Rik J Lories
01 Feb 2025
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database.
Qingran Yan ... Oliver Distler
Annals of the rheumatic diseases | VOL. -
Qingran Yan, et. al.Qingran Yan ... Oliver Distler
01 Feb 2025
Reduced organ damage accumulation in adult patients with SLE on anifrolumab plus standard of care compared to real-world external controls.
Zahi Touma ... Miina Waratani
Annals of the rheumatic diseases | VOL. -
Zahi Touma, et. al.Zahi Touma ... Miina Waratani
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.